Abstract

Noninvasive tomographic imaging of cellular processes in vivo may provide valuable cytological and histological information for disease diagnosis. However, such strategies are usually hampered by optical aberrations caused by the imaging system and tissue turbidity. State-of-the-art aberration correction methods require that the light signal be phase stable over the full-field data acquisition period, which is difficult to maintain during dynamic cellular processes in vivo. Here we show that any optical aberrations in the path length difference (OPD) domain can be corrected without the phase stability requirement based on maximum intensity assumption. Specifically, we demonstrate a novel optical tomographic technique, termed amplitude division aperture synthesis optical coherence tomography (ADAS-OCT), which corrects aberrations induced by turbid tissues by physical aperture synthesis and simultaneously data acquisition from sub-apertures. Even with just two sub-apertures, ADAS-OCT enabled in vivo visualization of red blood cells in human labial mucosa. We further demonstrated that adding sub-apertures could significantly scale up the aberration correction capability. This technology has the potential to impact a number of clinical areas where noninvasive examinations are preferred, such as blood count and cancers detection.

Highlights

  • Imaging pathophysiological processes at the cellular level is critical for understanding and diagnosis of human diseases, which is routinely realized through cytological or histological examinations following biopsies in clinical settings

  • We show that ADAS-OCT can deliver clear images of rapidly moving blood cells by restoring the spatial resolution degraded by the aberrations caused by the human mucosa in vivo

  • Our approach avoids the phase stability issue encountered by existing computational-based aberration-correction methods

Read more

Summary

Introduction

Imaging pathophysiological processes at the cellular level is critical for understanding and diagnosis of human diseases, which is routinely realized through cytological or histological examinations following biopsies in clinical settings. Tomographic imaging modalities are the mainstay of noninvasive diagnostic tools, including ultrasound imaging [1], computed tomography [2], magnetic resonance imaging [3] and positron emission tomography [4]. These (2020) 1:9 existing tools have fundamentally changed clinical practice and basic research, cellularlevel cytological and histological information is still not available in tomograms in vivo due to the limited spatial resolution. Sample-induced aberrations in turbid tissues generally vary spatially and temporally They must be corrected before clear images of cells can be obtained in vivo

Methods
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call